STUDY ON THE ASSOCIATION OF OBESITY INDICES WITH INFLAMMATORY MARKERS IN PRE-DIABETES AND DIABETES
Objective: In this study, the main objective was to evaluate the association of markers of obesity with the inflammatory markers in pre-diabetes and diabetes.
Methods: This study recruited 300 participants (100 control group, 100 pre-diabetic group, and 100 diabetic group). The anthropometric variables such as body mass index (BMI), waist-hip ratio (WHR), and waist circumference (WC), and biochemical variables such as fasting blood glucose, glycated hemoglobin, uric acid, C-reactive protein (CRP), fibrinogen, interleukin-6 (IL-6), and adiponectin were analyzed in each participant by standard methods.
Results: The present study documented significantly high values of BMI and WHR in patient (pre-diabetic and diabetic) groups compared to the control group. Similarly, the level of adiponectin decreased and that of uric acid, CRP, fibrinogen, and IL-6 increased significantly. Both BMI and WC were correlated significantly with inflammatory mediators in diabetic patients. The correlation with adiponectin was negative. In the pre-diabetic group, a significant correlation was observed only between WHR, adiponectin, and uric acid.
Conclusion: This study supports the fact that obesity-induced systemic inflammation of low grade is significantly associated with pre-diabetes and diabetes, thereby keeping these individuals at high risk of future complications especially cardiovascular diseases.
2. Saad EA, Habib SA, Refai WA, Elfayoumy AA. Malondialdehyde, adiponectin, nitric oxide, C-reactive protein, tumor necrosis factor-alpha and insulin resistance relationships and inter-relationships in Type 2 diabetes early stage. Is metformin alone adequate in this stage? Int J Pharm Pharm Sci 2017;9:176-81.
3. Sidossis L, Kajimura S. Brown and beige fat in humans: Thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest 2015;125:478-86.
4. Antonopoulos AS, Margaritis M, Coutinho P, Shirodaria C, Psarros C, Herdman L, et al. Adiponectin as a link between Type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: The regulatory role of perivascular adipose tissue. Diabetes 2015;64:2207- 19.
5. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R. State of the union between metabolism and the immune system in Type 2 diabetes. Genes Immun 2011;12:239-50.
6. Ray A, Huisman MV, Tamsma JT, Research and Writing-group, van Asten J, Bingen BO, et al. The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in Type 2 diabetes mellitus. Eur J Intern Med 2009;20:253-60.
7. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-9.
8. Vinkatesh G, Jayprakash A, Swathi KS. The effect of sun light exposure on prediabetic patients in South Indian population. Int J Pharm Pharm Sci 2014;6:107-10.
9. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH, et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
10. Cornier MA, Després JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: A scientific statement from the American heart association. Circulation 2011;124:1996-2019.
11. Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003;52:1256-64.
12. Verma ML, Verma V, Srivastava A. Prevalence of pre-diabetes among the general population in a tertiary care hospital in North India. Indian J Basic Appl Med Res 2017;6:433-8.
13. Ahmad J, Masoodi MA, Ashraf M, Rashid R, Ahmad R, Ahmad A, et al. Prevalence of diabetes mellitus and its associated risk factors in age group of 20 years and above in Kashmir, India. Al Ameen J Med Sci 2011;4:38-44.
14. Malini DS, Sahu A, Mohapatro S, Tripathy R. Assessment of risk factors for development of Type-2 diabetes mellitus among working women in Berhampur, Orissa. Indian J Community Med 2009;34:232-6.
15. Inter Act Consortium, Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, et al. Long-term risk of incident Type 2 diabetes and measures of overall and regional obesity: The EPIC-interAct case-cohort study. PLoS Med 2012;9:e1001230.
16. Oda E, Kawai R. Comparison among body mass index (BMI), waist circumference (WC), and percent body fat (%BF) as anthropometric markers for the clustering of metabolic risk factors in Japanese. Intern Med 2010;49:1477-82.
17. Janghorbani M, Amini M. Comparison of body mass index with abdominal obesity indicators and waist-to-stature ratio for prediction of Type 2 diabetes: The Isfahan diabetes prevention study. Obes Res Clin Pract 2010;4:e1-82.
18. Upadhyaya S, Kadamkode V, Mahammed R, Doraiswami C, Banerjee G. Adiponectin and IL-6: Mediators of inflammation in progression of healthy to Type 2 diabetes in Indian population. Adipocyte 2014;3:39-45.
19. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing Type 2 diabetes mellitus. JAMA 2001;286:327-34.
20. Kafle DR, Shrestha P. Study of fibrinogen in patients with diabetes mellitus. Nepal Med Coll J 2010;12:34-7.
21. Srikanth S, Lavanya Y, Sushma K. Relationship between serum uric acid and BMI in pre-diabetics and Type II diabetics in rural population a pilot study. Biomed Rev J Basic Appl Med Sci 2014;1:41-7.
22. Kong SE, Kang YE, Joung KH, Lee JH, Kim HJ, Ku BJ, et al. Plasma adiponectin levels in elderly patients with prediabetes. Endocrinol Metab (Seoul) 2015;30:326-33.
23. Uslu S, Kebapçi N, Kara M, Bal C. Relationship between adipocytokines and cardiovascular risk factors in patients with Type 2 diabetes mellitus. Exp Ther Med 2012;4:113-20.
24. Sachan P, Khan MM, Pisharody I. A cross sectional study showing association of C-reactive protein (C-RP) with prediabetes and diabetes in Indian population. J Biol Chem Res 2017;34:683-7.
25. Shantaram M, Nayak S. Relationship of hs-CRP level in diabetic persons free from micro and macrovascular disease. Int J Res Dev Pharm Life Sci 2014;3:1070-3.
26. Kluppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C, et al. Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of Type 2 diabetes: The KORA S4/F4 study. Diabetologia 2015;58:2269-77.
27. Malenica M, Šilar M, Duji? T, Bego T, Semiz S, Škrbo S, et al. Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with Type 2 diabetes mellitus. Med Glas (Zenica) 2017;14:169-75.
28. Agrawal A, Hegde A, Yadav C, Ahmad A, Manjrekar PA, Rukmini MS. IL-6 and impaired fasting glucose. Indian J Biochem Biophys 2018;55:424-8.
29. Harsoor S, Kinagi A, Ananta A. Correlation of plasma fibrinogen with blood pressure, BMI, lipid profile and glycemic status in Type 2 DM. J Evol Med Dent Sci 2014;3:14615-27.
30. Urbanavicius V, Abraitiene A, Vitkus D, Borovkiene R, Kucinskiene ZS. Adiponectin and uric acid in pre-diabetes and early Type 2 diabetes mellitus. Acta Med Litu 2015;15:81-7.
31. Rajala MW, Scherer PE. Minireview: The adipocyte at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003;144:3765-73.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.